Osaic Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Osaic Holdings's ENTA Position: Q1 2026 in Review
Osaic Holdings sold out of Enanta Pharmaceuticals (ENTA) in Q1 2026, closing a stake of 18 shares — an estimated $284 sold.
Osaic Holdings first reported a position in ENTA in Q1 2020 and held it in 24 quarters. The position peaked at $6K in Q4 2021. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Osaic Holdings reported no remaining Enanta Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 18 Enanta Pharmaceuticals shares in Q1 2026, an estimated $284.
- Osaic Holdings first reported a position in Enanta Pharmaceuticals in Q1 2020 and held it in 24 quarters.
- Osaic Holdings's Enanta Pharmaceuticals position peaked at $6K in Q4 2021.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.